Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.

doi:10.1373/clinchem.2007.096479

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.

Clinical chemistry - 1 May 2008

Mälarstig Anders, Eriksson Per, Rose Lynda, Diehl Kirsti A, Hamsten Anders, Ridker Paul M, Zee Robert Y L

Abstract excerpt

BACKGROUND: Recent data have implicated tumor necrosis factor (ligand) superfamily, member 4 (TNFSF4) gene variation in myocardial infarction in women; however, no prospective data are available on either incident arterial or venous disorders. METHODS: We evaluated 2 previously characterized TNFSF4 gene variants (-921C>T and dbSNP rs3850641) with a) incident arterial events using a prospective case-cohort design...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Ischemia

Share to Coronary Disease

Share to Myocardial Infarction

Share to OX40 Ligand

Share to Stroke

Share to Thrombosis

Share to Venous Thromboembolism

Source

Open in PubMed

Identifiers

PMID: 18356244
DOI: 10.1373/clinchem.2007.096479

Genes

TNFSF4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.PMID 18356244Read ↗

An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study.Semantic proximity Read ↗

Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.Semantic proximity Read ↗

Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study.Semantic proximity Read ↗

Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.Semantic proximity Read ↗

Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.Semantic proximity Read ↗

Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease.Semantic proximity Read ↗

Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism.Semantic proximity Read ↗

Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study.Semantic proximity Read ↗

Cross-Ancestry Investigation of Venous Thromboembolism Genomic PredictorsSemantic proximity Read ↗

Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.Semantic proximity Read ↗

The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes.Semantic proximity Read ↗

Mitochondrial genome association study with peripheral arterial disease and venous thromboembolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.